Breaking News on Contract Research, Manufacturing & Clinical Trials

Top Headlines

PCT Europe 2015

Big Pharma; Big bureaucracy; Big trial delays, says PCT panel

Big Pharma bureaucracy makes trials less efficient but listening to CRO partners can help reverse this, say experts from Pfizer, Bayer and  Grunenthal.

Acquired Sigma-Aldrich businesses part of Merck's Africa growth plan

New acquisition Sigma Aldrich will play a part in African growth plans in addition to giving it a presence in the preclinical services sector says Merck*.

Bigger in Japan: Biopta CEO predicts preclinical CRO business growth under new owners

Preclinical CRO Biopta will add stem cell programming tech to its offering, expand in Japan and nearly double its workforce under new owner, Reprocell.

Pfizer-Allergan deal: what next for contract manufacturers?

As CMOs wait to see the short-term fallout of the Pfizer-Allergan deal, an M&A expert says contract manufacturing will follow the CRO industry in embracing strategic alliances and consolidation.


Strategic CRO relationships no more effective than traditional models, Tufts

Inconsistent practices and a lack of trust are restricting sponsors from fully realising the potential of CRO strategic partnerships, according to Tufts' Director Kenneth Getz.

Xellia buys ex-Ben Venue site and aims to restart production in 2017

Restarting production at the former Ben Venue facility in Ohio will be a “significant task” says Xellia Pharmaceuticals which plans to invest after buying the site from Hikma.

Key Industry Events


Access all events listing

Our events, Shows & Conferences...